Nonrulemaking
FDA
Open for Comments
FDA-2020-D-1079
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry; Availability
4 docs67 comments
Comments due Sep 22, 2020
This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.
Showing 30 of 12,996 dockets
FDA-2020-D-1079
DOT-OST-2004-17563
NHTSA-2026-0463
CNCS-2026-0265
FAA-2005-22227
FAA-2016-9250
FAA-2017-0329
FAA-2024-1593
FAA-2026-6568
FAA-2026-7395
FAA-2026-7396
FAA-2026-8284
FDA-2026-D-1255
FDA-2026-H-5357
FDA-2026-V-7865
FAA-2026-7888
FAA-2026-6569
FDA-2025-H-3890
FDA-2026-H-0706